AU Patent

AU2007203525C1 — Methods of Inducing Terminal Differentiation

Assigned to Merck HDAC Research LLC · Expires 2009-02-05 · 17y expired

What this patent protects

Patent listed against Zolinza.

Drugs covered by this patent

Zolinza (VORINOSTAT) · Merck & Co.

Patent Metadata

Patent number: AU2007203525C1
Jurisdiction: AU
Classification: —
Expires: 2009-02-05
Drug substance claim: No
Drug product claim: No
Assignee: Merck HDAC Research LLC
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.